These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3028867)

  • 1. Cardio-pulmonary elimination of 5-fluorouracil after bolus injection in the hepatic artery.
    Andersson M; Billström A; Domellöf L; Gustavsson B
    Eur J Surg Oncol; 1987 Feb; 13(1):35-9. PubMed ID: 3028867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Peripheral 5-FU blood concentration after high-dose injection into the hepatic artery: potential preventive effect on extrahepatic metastatic foci].
    Yamamoto Y; Kakisaka A; Minami M; Goto J; Ohara K; Isizaki A; Kino S; Kono T; Kasai S
    Gan To Kagaku Ryoho; 1999 Jul; 26(8):1159-62. PubMed ID: 10431582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical study of low-dose cisplatin and 5-fluorouracil chemotherapy via implanted fusion port in 20 patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis].
    Naganuma A; Toyoda M; Hamada T; Hagiwara S; Yanagisawa M; Kosone T; Arai H; Abe T; Takagi H
    Gan To Kagaku Ryoho; 2007 May; 34(5):729-34. PubMed ID: 17496446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans.
    Speyer JL; Sugarbaker PH; Collins JM; Dedrick RL; Klecker RW; Myers CE
    Cancer Res; 1981 May; 41(5):1916-22. PubMed ID: 7214359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of 5-fluorouracil following different routes of intrahepatic administration in the canine model.
    Didolkar MS; Covell DG; Jackson AJ; Walker AP; Kalidindi SR
    Cancer Res; 1984 Nov; 44(11):5105-9. PubMed ID: 6488170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.
    Yamasaki T; Kimura T; Kurokawa F; Aoyama K; Ishikawa T; Tajima K; Yokoyama Y; Takami T; Omori K; Kawaguchi K; Tsuchiya M; Terai S; Sakaida I; Okita K
    J Gastroenterol; 2005 Jan; 40(1):70-8. PubMed ID: 15692792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic artery infusion using oxaliplatin in combination with 5-fluorouracil, folinic acid and mitomycin C: oxaliplatin pharmacokinetics and feasibility.
    Guthoff I; Lotspeich E; Fester C; Wallin I; Schatz M; Ehrsson H; Kornmann M
    Anticancer Res; 2003; 23(6D):5203-8. PubMed ID: 14981990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic arterial infusion of 5-fluorouracil and cisplatin for unresectable or recurrent hepatocellular carcinoma with tumor thrombus of the portal vein.
    Itamoto T; Nakahara H; Tashiro H; Haruta N; Asahara T; Naito A; Ito K
    J Surg Oncol; 2002 Jul; 80(3):143-8. PubMed ID: 12115797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with hepatic arterial infusions.
    Sanderson TA; McBride CM
    Tex Med; 1971 Mar; 67(3):52-6. PubMed ID: 4326061
    [No Abstract]   [Full Text] [Related]  

  • 10. [Continuous hepatic arterial infusion chemotherapy with low-dose CDDP plus 5-FU for liver metastases from colorectal carcinoma].
    Kohnoe S; Taketomi A; Morita M; Baba H; Matsuoka H; Seo Y; Saito T; Tomoda H
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1429-32. PubMed ID: 8854771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical study on continuous 5-FU infusion for the treatment of primary liver cancer].
    Matsui K; Tomoe T; Terajima S; Yamasato M; Kondo J
    Gan No Rinsho; 1970 Jan; 16(1):43-7. PubMed ID: 4312484
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatic resection followed by IFN-alpha and 5-FU for advanced hepatocellular carcinoma with tumor thrombus in the major portal branch.
    Nagano H; Sakon M; Eguchi H; Kondo M; Yamamoto T; Ota H; Nakamura M; Wada H; Damdinsuren B; Marubashi S; Miyamoto A; Takeda Y; Dono K; Umeshit K; Nakamori S; Monden M
    Hepatogastroenterology; 2007; 54(73):172-9. PubMed ID: 17419255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The evaluation of weekly hepatic arterial infusion of high-dose 5-FU for liver metastases from colorectal cancer].
    Hata Y; Morita S; Noda Y; Kawasaki R; Morita Y; Awatani T; Horimi T
    Gan To Kagaku Ryoho; 1998 May; 25(6):901-5. PubMed ID: 9617329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of 5-fluorouracil concentration in peripheral blood and side effects in continuous hepatic arterial infusion chemotherapy for patients with unresectable liver cancer].
    Fujii K; Nakashima K; Ohno T; Anai H
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1835-7. PubMed ID: 9382545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of spindle cell type hepatocellular carcinoma responding to hepatic intra-arterial infusion chemotherapy].
    Maruyama T; Nozue M; Aoyagi H; Sakamoto T; Fukue M; Matsui S; Kodaira Y; Monma E; Takada Y; Shidara S; Ikezawa K; Yoshida T; Shimakura S
    Gan To Kagaku Ryoho; 2002 Jan; 29(1):137-41. PubMed ID: 11816471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steady-state nonlinear pharmacokinetics of 5-fluorouracil during hepatic arterial and intravenous infusions in cancer patients.
    Wagner JG; Gyves JW; Stetson PL; Walker-Andrews SC; Wollner IS; Cochran MK; Ensminger WD
    Cancer Res; 1986 Mar; 46(3):1499-506. PubMed ID: 3943107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epirubicin pharmacokinetics after intrahepatic arterial and intraperitoneal administration.
    Strocchi E; Camaggi CM; Rossi AP; Angelelli B; Comparsi R; Franchini A; Del Prete P; Cola B; Pannuti F
    Drugs Exp Clin Res; 1985; 11(4):295-301. PubMed ID: 3013561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Complete responses in patients with unresectable liver metastases from colorectal cancer with weekly high-dose 5-FU plus one-shot CDDP HAI].
    Udagawa M; Okabe S; Kuwabara H; Ootsukasa S; Arai T; Maruyama S; Murase N; Yamashita H; Iwai T
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1709-12. PubMed ID: 10560377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lattice intrahepatic doxorubicin with and without in-flow occlusion: a pharmacokinetic study of direct liver injection.
    Averbach A; Stuart OA; Chang D; Sugarbaker PH
    Eur J Surg Oncol; 2000 Feb; 26(1):73-9. PubMed ID: 10718184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A clinical study of hepatic arterial infusion chemotherapy with low-dose CDDP and 5-FU for liver metastases].
    Yonemitsu K; Sugihara S; Toyama E; Tsuruta Y; Teshima K; Tanaka M
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1963-6. PubMed ID: 16282736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.